The prognostic relevance, expression pattern, genetic modification, and immunological connection of Bcl2 in the diverse breast cancer subtypes were investigated using the tools GEPIA, Bc GeneExminer, UALCAN, TIMER 2.0, ENRICHR, and TISCH. The gene discussed is BCL2; the disease is breast carcinoma.